This mechanism was reported for MYC in embryonic stem cells (ESCs) and for overexpressed N-MYC in neuroblastoma [43,44], indicating that the decreased H3K9me3 deposition plays a role for both MYC’s physiologic as well as its oncogenic function. Here, MYC is linked to neuroblastoma.